Pages that link to "Q40818252"
Jump to navigation
Jump to search
The following pages link to A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentation (Q40818252):
Displaying 34 items.
- Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine (Q28387636) (← links)
- A Multi-Vector, Multi-Envelope HIV-1 Vaccine (Q28389250) (← links)
- Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials (Q28394899) (← links)
- Vaccine development against HIV-1: current perspectives and future directions. (Q30329791) (← links)
- UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV. (Q30414377) (← links)
- Immunization with plasmid DNA expressing the caprine arthritis-encephalitis virus envelope gene: quantitative and qualitative aspects of antibody response to viral surface glycoprotein. (Q31887780) (← links)
- Nucleic acid vaccines: tasks and tactics. (Q34510525) (← links)
- Limited breadth of a T-helper cell response to a human immunodeficiency virus envelope protein (Q34781685) (← links)
- HIV-1 vaccines: the search continues (Q34876150) (← links)
- Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza (Q35023393) (← links)
- Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing (Q35277600) (← links)
- A critical examination of current HIV therapies (Q35555194) (← links)
- A comparative analysis of HIV-specific mucosal/systemic T cell immunity and avidity following rDNA/rFPV and poxvirus-poxvirus prime boost immunisations (Q35628697) (← links)
- Molecular mechanisms of HIV-1 associated neurodegeneration (Q36211491) (← links)
- Murine Monoclonal Antibodies for Antigenic Discrimination of HIV-1 Envelope Proteins (Q36475897) (← links)
- Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity (Q37590335) (← links)
- Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediate (Q39591919) (← links)
- The HIV-1 chimeric protein CR3 expressed by poxviral vectors induces a diverse CD8+ T cell response in mice and is antigenic for PBMCs from HIV+ patients. (Q40616719) (← links)
- Immunization with DNA, adenovirus or both in biodegradable alginate microspheres: effect of route of inoculation on immune response (Q42798830) (← links)
- Optimization of DNA immunization against human cytomegalovirus (Q43654256) (← links)
- Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV. (Q44189653) (← links)
- Subcutaneous administration of a recombinant vaccinia virus vaccine expressing multiple envelopes of HIV-1. (Q45698142) (← links)
- The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36 (Q45728663) (← links)
- Immunization of pigs against influenza virus infection by DNA vaccine priming followed by killed-virus vaccine boosting (Q45737947) (← links)
- Multi-Envelope HIV-1 Vaccine Development: Two Targeted Immune Pathways, One Desired Protective Outcome. (Q47218587) (← links)
- Multi-envelope HIV vaccine safety and immunogenicity in small animals and chimpanzees. (Q52844350) (← links)
- DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice. (Q55036231) (← links)
- Long lived multi-isotype anti-HIV antibody responses following a prime-double boost immunization strategy (Q55877037) (← links)
- Cellular immune responses to helper-free HSV-1 amplicon particles encoding HIV-1 gp120 are enhanced by DNA priming (Q58661772) (← links)
- HIV vaccines: Biological and clinical considerations (Q60920348) (← links)
- A prime-boost immunization strategy with DNA and recombinant baculovirus-expressed protein enhances protective immunogenicity of glycoprotein D of equine herpesvirus 1 in naïve and infection-primed mice (Q73318524) (← links)
- Interleukin-18 modulates immune responses induced by HIV-1 Nef DNA prime/protein boost vaccine (Q74106318) (← links)
- A highly sensitive single-cell assay detects T-helper cell responses missed by conventional interleukin-2-based methods (Q77492279) (← links)
- Clustering of Th Cell Epitopes on Exposed Regions of HIV Envelope Despite Defects in Antibody Activity (Q79125450) (← links)